Pharmaceutical companies approach a significant wave of patent expirations by 2030. This includes exclusivity rights set to expire for 569 medications valued at $278 billion, based on 2022 sales.¹ As ...
Every time Jaclyn publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback